G-CSF receptor — Drug Target
All drugs that target G-CSF receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Marketed (2)
- early leukostim · Hyuk moon Kim · Growth factor · Oncology
Early leukostim stimulates the production of white blood cells. - late leukostim · Hyuk moon Kim · Growth factor · Oncology
Late leukostim stimulates the proliferation of hematopoietic progenitor cells.
Phase 3 pipeline (5)
- YPEG-rhG-CSF · Xiamen Amoytop Biotech Co., Ltd. · G-CSF agonist · Oncology
PEG-rhG-CSF is a recombinant human granulocyte colony-stimulating factor (G-CSF) conjugated with polyethylene glycol (PEG), which helps stimulate the production of white blood cells. - Placebo+G-CSF · Guangzhou Gloria Biosciences Co., Ltd. · Oncology
G-CSF stimulates the bone marrow to produce more neutrophils, a type of white blood cell. - Pegylated G-CSF · Australasian Gastro-Intestinal Trials Group · Growth factor · Oncology
Pegylated G-CSF stimulates the production of white blood cells, specifically neutrophils, to help the body fight infection. - rhG-CSF/PEG-rhG-CSF · Xiamen Amoytop Biotech Co., Ltd. · Growth factor · Oncology
rhG-CSF/PEG-rhG-CSF stimulates the production of white blood cells. - pegylated filgrastim and filgrastim · Chinese Academy of Medical Sciences · G-CSF agonist · Oncology
Pegylated filgrastim and filgrastim stimulate the production of white blood cells, specifically neutrophils, to help the body fight infection.
Phase 2 pipeline (3)
- Injection of Filgrastim · Centre Leon Berard · G-CSF agonist · Oncology
Filgrastim stimulates the production of white blood cells, specifically neutrophils, to help the body fight infection. - G-CSF and plerixafor · Genzyme, a Sanofi Company · Growth factor · Oncology
Stimulates the production of neutrophils by binding to the G-CSF receptor - Filgrastim Injectable Product · Recardio, Inc. · G-CSF agonist · Oncology
Stimulates the production of white blood cells by binding to and activating the G-CSF receptor.